Daijiworld Media Network - New Delhi

New Delhi, Dec 29: As many people look to the New Year as an opportunity to reset their lifestyles and adopt healthier habits, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has cautioned the public to be vigilant about the safety and legitimacy of weight-loss medicines.

In a statement issued on Monday, the MHRA warned of serious health risks associated with purchasing weight-loss products from unregulated websites or through social media platforms. Such products, it said, are often sold illegally and may be counterfeit, contaminated, incorrectly dosed, or contain potent ingredients that are not listed on the label.

The agency noted that the use of such medicines can result in dangerous side effects, including heart-related complications, psychological issues and severely low blood sugar levels.

“Licensed and appropriate obesity medicines can offer real benefits for people with a genuine clinical need, but they must only be obtained from registered pharmacies with a valid prescription,” the statement quoted UK Health Minister Zubir Ahmed, who is also a practising doctor.

The MHRA advised consumers not to buy prescription-only medicines without a prescription and stressed the importance of sourcing medicines solely from registered pharmacies or authorised retailers. It also urged people to be wary of weight-loss products advertised on social media, particularly those claiming rapid results, “miracle cures,” or unusually low prices—common indicators of illegal sellers.

For anyone considering weight-loss treatment, the regulator recommended consulting a general practitioner, pharmacist or another qualified healthcare professional to discuss safe and evidence-based options.

“People often look for ways to improve their health at this time of year, but buying medicines from illegal online sellers can put them at serious risk,” said Jenn Matthissen from the MHRA’s Safety and Surveillance team. She emphasised the need to use authorised products and seek professional medical advice.

The MHRA, which operates under the UK Department of Health and Social Care, oversees the regulation of medicines and medical devices to ensure they meet safety, quality and effectiveness standards.

Similar concerns have been raised in the United States, where the Food and Drug Administration (FDA) has previously warned against unapproved drugs marketed for weight loss, noting that such products bypass regulatory checks and may pose significant risks to patients.